Antibacterial activity of coumermycin alone and in combination with other antibiotics
Open Access
- 1 June 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (6) , 687-689
- https://doi.org/10.1128/aac.25.6.687
Abstract
Coumermycin has been shown to inhibit Staphylococcus aureus and Staphylococcus epidermidis strains that are susceptible and those that are resistant to methicillin at concentrations less than or equal to 0.05 micrograms/ml. Listeria monocytogenes and Corynebacterium spp. resistant to cephalosporins were inhibited by less than or equal to 1.6 micrograms of coumermycin ml, and streptococcal species, with the exception of Streptococcus faecalis, were inhibited by 0.1 micrograms/ml. Cross-resistance with beta-lactams or aminoglycosides was not found. Coumermycin acted synergistically with ofloxacin, norfloxacin, and enoxacin against S. aureus but did not show synergy when combined with nafcillin, vancomycin, or rifampin. Coumermycin did not inhibit members of the family Enterobacteriaceae or Pseudomonas aeruginosa.This publication has 8 references indexed in Scilit:
- Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve methodAntimicrobial Agents and Chemotherapy, 1982
- Therapeutic Granulocyte Transfusions for Documented InfectionsAnnals of Internal Medicine, 1982
- Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with GranulocytopeniaAnnals of Internal Medicine, 1982
- Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growthAntimicrobial Agents and Chemotherapy, 1982
- The Emergence of Methicillin-Resistant Staphylococcus aureusAnnals of Internal Medicine, 1982
- Antistaphylococcal Activity of Rifampin with Other AntibioticsThe Journal of Infectious Diseases, 1981
- Pharmacokinetic Profile of Coumermycin A1Journal of Pharmaceutical Sciences, 1970